There are three distinct types of neurofibromatosis, or NF: neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2) and schwannomatosis.
For more information or to request an appointment, please call the Johns Hopkins Neurofibromatosis Center at 410-502-6732.
Neurofibromatosis: What You Need to Know
Neurofibromatosis type 1 (NF1) is a common, inherited neurological disorder that affects 1 in 3,000 people.
- NF1 involves the skin, nervous system and eyes and can be mild or severe.
- It is characterized by six or more light brown skin spots (café au lait spots), unusual freckles, colored bumps on the iris of the eye (Lisch nodules) or neurofibromas.
- NF1 is also called Von Recklinghausen’s disease.
- About 15% of people with NF1 develop gliomas.
- Read more about the symptoms, associated tumors, diagnosis, risk factors and treatment of NF1.
Neurofibromatosis type 2 (NF2) is much rarer, affecting only 1 in 25,000 people. It can cause severe hearing loss, tinnitus (ringing in the ears) and other neurologic problems such as weakness.
Schwannomatosis is a condition that is characterized by the growth of nerve tumors throughout the body. These tumors can be extremely painful and debilitating.Read more about the symptoms, diagnosis, risk factors and treatment of schwannomatosis.
Learn more about neurofibromatosis (NF): See "Neurocutaneous Syndromes" in our Health Library.
Why choose Johns Hopkins for treatment of neurofibromatosis?
A multidisciplinary team of doctors and specialists offers comprehensive treatment to address neurofibromatosis.
Meet our physicians:
The Johns Hopkins Comprehensive Neurofibromatosis Center addresses the myriad symptoms and presentations of these complex and lifelong disorders, including use of observation, surgery, medication (including chemotherapy where appropriate), radiotherapy, hearing aids and cochlear implants, vestibular training, behavioral therapy and pain management.
The Johns Hopkins Comprehensive Neurofibromatosis Center (JHCNC) is part of a national and international collaboration of medical centers and providers seeking to find the best treatments for patients and to advance research. To learn more about our clinical studies, visit the Johns Hopkins Institute for Clinical and Translational Research.